Literature DB >> 8243849

Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area.

E Standl1, H Stiegler.   

Abstract

Still under debate is the prevalence of microalbuminuria in patients with recently diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and its relation to existing macro-vascular disease and the major vascular risk markers. Hence, from a representative sample of 1512 patients with Type 2 diabetes of varied duration (recruited from 22 non-specialized medical practices of the Greater Munich Area) 68 (26 males, 42 females) of 71 eligible subjects with a known duration of diabetes of up to 17 weeks and not less than 4 weeks were examined in the present study. Median age was 61 (39 to 75) years, prevalence of ischaemic heart disease (case history plus ECG, Minnesota code, Whitehall criteria) 41.2%, and that of peripheral vascular and carotid artery disease (both assessed by ultrasound-Doppler) were 35.3 and 4.4%, respectively. Diabetes was well controlled (HbA1c: 6.9%, 5.6-8.3; fasting blood glucose: 7.7 mmol/l, 5.4-10.4; median +/- interquartile range IQ), the cardiovascular risk profile was most prominent in terms of triglycerides (3.1 mmol/l, 2.1-4.6, median +/- IQ range) and systolic blood pressure (164 mm Hg, 140-186, median +/- IQ range). 13.2% showed signs of urinary tract infection. Of the remainder, 19.0% exhibited microalbuminuria (RIA, > 30-200 mg/l), and 5.2% macroalbuminuria (> 200 mg/l). Significant correlations (p < 0.05) were found between urinary albumin concentration and beta 2-microglobulin in serum, systolic blood pressure, serum triglycerides, serum HDL-cholesterol (inversely), HbA1c, and peripheral vascular disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243849     DOI: 10.1007/bf02374493

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Prospective study of microalbuminuria as predictor of mortality in NIDDM.

Authors:  M B Mattock; N J Morrish; G Viberti; H Keen; A P Fitzgerald; G Jackson
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

2.  Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

Authors:  J S Yudkin; R D Forrest; C A Jackson
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

3.  Microalbuminuria as predictor of increased mortality in elderly people.

Authors:  E M Damsgaard; A Frøland; O D Jørgensen; C E Mogensen
Journal:  BMJ       Date:  1990-02-03

4.  The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis.

Authors:  A W Patrick; P J Leslie; B F Clarke; B M Frier
Journal:  Diabet Med       Date:  1990-12       Impact factor: 4.359

5.  Prospective analysis of the insulin-resistance syndrome (syndrome X).

Authors:  S M Haffner; R A Valdez; H P Hazuda; B D Mitchell; P A Morales; M P Stern
Journal:  Diabetes       Date:  1992-06       Impact factor: 9.461

6.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

7.  Microalbuminuria in diabetes: relationships between urinary albumin excretion and diabetes-related variables.

Authors:  W Gatling; M A Mullee; C Knight; R D Hill
Journal:  Diabet Med       Date:  1988 May-Jun       Impact factor: 4.359

8.  Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru.

Authors:  V R Collins; G K Dowse; C F Finch; P Z Zimmet; A W Linnane
Journal:  Diabetes       Date:  1989-12       Impact factor: 9.461

9.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

Authors:  J Eriksson; A Franssila-Kallunki; A Ekstrand; C Saloranta; E Widén; C Schalin; L Groop
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

10.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

View more
  8 in total

Review 1.  Complications of diabetes: renal disease and promotion of self-management.

Authors:  A Melville; R Richardson; D Lister-Sharp; A McIntosh
Journal:  Qual Health Care       Date:  2000-12

Review 2.  [Nephropathy and hypertension in type II diabetes].

Authors:  E Ritz; K Bergis; K Strojek; C Keller
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 3.  Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Authors:  Merlin C Thomas; Robert C Atkins
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.

Authors:  A Schmitz; M Vaeth; C E Mogensen
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

Review 5.  Hypertension and insulin resistance. Glycaemia and insulinaemia in overweight hypertensive patients.

Authors:  B Weichenhain; H J van Kooten; E Standl
Journal:  Drugs       Date:  1993       Impact factor: 9.546

6.  Diabetes and cardiovascular disease.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2011-03       Impact factor: 19.112

7.  Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study.

Authors:  Christa Meisinger; Margit Heier; Rüdiger Landgraf; Michael Happich; H-Erich Wichmann; Wolfgang Piehlmeier
Journal:  BMC Health Serv Res       Date:  2008-11-05       Impact factor: 2.655

8.  Association between serum uric acid, urinary albumin excretion, and glycated hemoglobin in Type 2 diabetic patient.

Authors:  Sunita Neupane; Raju Kumar Dubey; Narayan Gautam; Krishna Kumar Agrawal; Archana Jayan; Sujata Shrestha; Amit Chandra Jha
Journal:  Niger Med J       Date:  2016 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.